ETF Managers Group’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

ETF Managers Group’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$99.5K	Buy	43,836 +12,409	+39%	+$31.5K	﹤0.01%	634
2022 Q4	$44K	Sell	31,427 -5,762	-15%	-$9.68K	﹤0.01%	500
2022 Q3	$74K	Sell	37,189 -2,617	-7%	-$5.45K	﹤0.01%	662
2022 Q2	$62K	Buy	39,806 +1,965	+5%	+$7.43K	﹤0.01%	699
2022 Q1	$167K	Sell	37,841 -43	-0.1%	-$237	﹤0.01%	610
2021 Q4	$211K	Buy	+37,884	New	+$392K	﹤0.01%	609

Other funds holding VAXX

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Scoggin Management New York $935M AUM 301.8% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

ETF Managers Group's VAXX Position: Q1 2023 in Review

ETF Managers Group increased its Vaxxinity, Inc. Class A Common Stock (VAXX) stake by 39% in Q1 2023, buying an estimated $31.5K and bringing the position to 43,836 shares worth $99.5K. The position accounts for ﹤0.01% of the portfolio, ranked #634.

ETF Managers Group first reported a position in VAXX in Q4 2021 and has held it in 6 quarters since. The position peaked at $211K in Q4 2021. 48 funds tracked by Wall St. Rank hold VAXX as of Q1 2023.

ETF Managers Group held 43,836 shares of Vaxxinity, Inc. Class A Common Stock worth $99.5K as of Q1 2023.
ETF Managers Group bought 12,409 Vaxxinity, Inc. Class A Common Stock shares in Q1 2023, an estimated $31.5K.
Vaxxinity, Inc. Class A Common Stock made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #634 holding.
ETF Managers Group first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and has held it in 6 quarters since.
ETF Managers Group's Vaxxinity, Inc. Class A Common Stock position peaked at $211K in Q4 2021.
48 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.